InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,599.60
(
1.04%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.36
(
-0.14%
)
Bitcoin
63,690.94
(
0.83%
)

Replies to post #94986 on $heff's $tation of $tocks & $olid DD

Replies to #94986 on $heff's $tation of $tocks & $olid DD

martych

09/08/16 3:24 PM

#95165 RE: $heff #94986

$TGTX Open label study results for ublituximab selected for presentation at European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS). Presentation on Sep 16 could be catalyst given recent orphan designation.